Federal Circuit Denies Mandamus Petition Challenging the PTO Director’s Application of ‘Settled Expectations’ in IPR Proceedings

December 9, 2025

Reading Time : 2 min

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

The key issue before the court was whether the Director acted within its authority when it denied institution of two IPR petitions based on “settled expectations” tied to the age of the challenged patents. The petitioner argued that the Director exceeded its statutory authority and violated procedural requirements by considering how long the patents had been in force. The petitioner also asserted that the PTO failed to promulgate the institution considerations through notice-and-comment rulemaking and that inclusion of “settled expectations” as a factor in the Director’s institution determination was arbitrary and capricious.

The court began its analysis by reiterating the stringent standard for mandamus relief, which requires a petitioner to demonstrate a clear and indisputable right to relief, lack of adequate alternative remedies, and that issuance of the writ is appropriate under the circumstances. The court emphasized that Congress committed institution decisions to the Director’s discretion and made such determinations “final and nonappealable” under 35 U.S.C. § 314(d). Citing precedent, the court noted that this bar on judicial review extends to decisions denying institution for efficiency reasons and generally encompasses challenges to the factors considered in making institution decisions.

The court then held the petitioner’s arguments insufficient to meet the demanding mandamus standards. It reasoned that challenges to rulemaking procedures could be pursued through an APA action in federal district court, meaning the petitioner had an adequate alternative remedy. The court rejected the petitioner’s arguments that the Director exceeded its authority by implementing the “settled expectations” factor, holding those arguments focus squarely on institution standards—standards that are generally not reviewable. The court also rejected petitioner’s constitutional claims, finding no colorable due process or separation-of-powers violation because there is no constitutional right to an IPR or to have a petition considered under specific criteria.

Practice Tip: The Federal Circuit’s decision highlights the difficulty in seeking mandamus relief based on the Director’s institution decision. This may represent an opportunity for patentees who face IPR or PGR challenges in front of the PTO to raise new arguments that justify denying institution. Patent challengers similarly should, in addition to raising strong substantive challenges, provide counterarguments for why settled expectations should not dictate denial of institution and may consider an APA suit in district court if their particular case warrants such a suit.

In re Cambridge Industries USA Inc., Case No. 2026-101 (Fed. Cir. Dec. 9, 2025).

Share This Insight

Previous Entries

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

IP Newsflash

March 12, 2026

The District of New Jersey recently denied the litigants’ request for a briefing schedule to resolve a dispute about a proposed discovery confidentiality order, and also denied extending the deadlines for the defendants’ invalidity and non-infringement contentions. At issue was the scope of the FDA and patent prosecution bars in the confidentiality order.

...

Read More

IP Newsflash

February 27, 2026

The USPTO Director denied a patent owner’s request for discretionary denial of two inter partes review (IPR) petitions, citing the petitioner’s “well-settled expectation” that it would not be accused of infringing the two challenged patents. The Director’s conclusion was based on the petitioner’s decade-long business relationship with the original owner of the challenged patents.

...

Read More

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.